Measles virus
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Breast Cancer ~ Swine Flu ~ Lung Cancer ~ Heart attack ~ Pregnancy ~ All Health Topics
Home / Health News / 2009 / January 2009 / January 22, 2009
Measles virus may offer prostate cancer treatment
RSS / Print / Comments

Prostate cancer

Coming soon: 'Magic pill' for men with aggressive prostate cancer

Gender-bending chemical in plastics 'ups prostate cancer risk'

New Data for Erbitux in Prevalent Cancers to Be Revealed at ESMO

More on Prostate cancer

Health News

New study confirms smoking, cancer link (reissue)
Taking up smoking results in epigenetic changes associated with the development of cancer, UK scientists have reported. ANI

Blame your mom for your muffin top or thunder thighs
A new study by an international team of researchers, including Cambridge and Oxford experts, has revealed that our propensity to be apple or pear-shaped is at least partly in our genes. ANI

Chemicals in mother's blood linked to child's obesity
A team of scientists has revealed that babies whose mothers had relatively high levels of the chemical DDE in their blood were more likely to both grow rapidly during their first 6 months and to have a high body ma*s index (BMI) by 14 months. ANI

Measles virus may offer prostate cancer treatment

A new study has found that certain measles vaccine strain derivatives may offer effective treatment for prostate cancer patients.

Washington, Jan 22 : A new study has found that certain measles vaccine strain derivatives may offer effective treatment for prostate cancer patients.

Certain strains including the one known as MV-CEA is found to effectively infect, replicate in and kill prostate cancer cells.

With help of virotherapy, the researchers found, that the median survival time of MV-CEA-treated mice almost doubled, and complete tumour regression was observed in one-fifth of treated animals.

"Based on our preclinical results as well as the safety of measles derivatives in clinical trials against other tumour types, these viral strains could represent excellent candidates for clinical testing against advanced prostate cancer, including androgen resistant tumours," said Evanthia Galanis, M.D., of the Mayo Clinic, senior author of the study.

These strains of measles virus are used as therapeutic agents against cancer that demonstrates no cross-resistance with existing treatment approaches, and can therefore be combined with conventional treatment methods.

The virotherapy agent can easily be applied directly to the prostate tumour via ultrasound-guided needle injections and close monitoring of therapy can be achieved by non-invasive techniques including ultrasound and MRI.

This study is published in The Prostate.


Link to this page

Suggested pages for your additional reading on Facebook

© 2000-2017 All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us